Skip to main content
Top
Published in: International Journal of Hematology 6/2016

01-06-2016 | Case Report

A Japanese family with X-linked sideroblastic anemia affecting females and manifesting as macrocytic anemia

Authors: Tatsuya Katsurada, Hiroshi Kawabata, Daiki Kawabata, Masahiro Kawahara, Yukiharu Nakabo, Akifumi Takaori-Kondo, Yataro Yoshida

Published in: International Journal of Hematology | Issue 6/2016

Login to get access

Abstract

X-linked sideroblastic anemia (XLSA) is a rare hereditary disorder that typically manifests in males as microcytic anemia. Here, we report a family with XLSA that affects females and manifests as macrocytic anemia. The proband was a Japanese woman harboring a heterozygous mutation c.679C>T in the ALAS2 gene. This mutation causes the amino acid substitution R227C, which disrupts the enzymatic activity of erythroid-specific δ-aminolevulinic acid synthase. The mutation was not detected in the ALAS2 complementary DNA from peripheral blood red blood cells of the proband, indicating that the cells were mostly derived from erythroblasts expressing wild-type ALAS2. The proband’s mother, who had been diagnosed with myelodysplastic syndrome, also had XLSA with the same mutation. Clinicians should be aware that XLSA can occur not only in males but also in females, in whom it manifests as macrocytic anemia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64–9.CrossRefPubMed Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64–9.CrossRefPubMed
2.
go back to reference Ohba R, Furuyama K, Yoshida K, Fujiwara T, Fukuhara N, Onishi Y, et al. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS). Ann Hematol. 2013;92:1–9.CrossRefPubMed Ohba R, Furuyama K, Yoshida K, Fujiwara T, Fukuhara N, Onishi Y, et al. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS). Ann Hematol. 2013;92:1–9.CrossRefPubMed
3.
go back to reference Fujiwara T, Harigae H. Pathophysiology and genetic mutations in congenital sideroblastic anemia. Pediatr Int. 2013;55:675–9.CrossRefPubMed Fujiwara T, Harigae H. Pathophysiology and genetic mutations in congenital sideroblastic anemia. Pediatr Int. 2013;55:675–9.CrossRefPubMed
4.
go back to reference Bottomley SS, Fleming MD. Sideroblastic anemia: diagnosis and management. Hematol Oncol Clin North Am. 2014;28:653–70.CrossRefPubMed Bottomley SS, Fleming MD. Sideroblastic anemia: diagnosis and management. Hematol Oncol Clin North Am. 2014;28:653–70.CrossRefPubMed
5.
go back to reference Cooley TB. A severe type of hereditary anemia with elliptocytosis: interesting sequence of splenectomy. Am J Med Sci. 1945;209:561–8.CrossRef Cooley TB. A severe type of hereditary anemia with elliptocytosis: interesting sequence of splenectomy. Am J Med Sci. 1945;209:561–8.CrossRef
6.
go back to reference Aoki Y, Urata G, Takaku F. Aminolevulinic acid synthetase activity in erythroblasts of patients with primary sideroblastic anemia. Nihon Ketsueki Gakkai Zasshi. 1973;36:74–7.PubMed Aoki Y, Urata G, Takaku F. Aminolevulinic acid synthetase activity in erythroblasts of patients with primary sideroblastic anemia. Nihon Ketsueki Gakkai Zasshi. 1973;36:74–7.PubMed
7.
go back to reference Yamamoto M, Nakajima O. Animal models for X-linked sideroblastic anemia. Int J Hematol. 2000;72:157–64.PubMed Yamamoto M, Nakajima O. Animal models for X-linked sideroblastic anemia. Int J Hematol. 2000;72:157–64.PubMed
8.
go back to reference Harigae H, Furuyama K. Hereditary sideroblastic anemia: pathophysiology and gene mutations. Int J Hematol. 2010;92:425–31.CrossRefPubMed Harigae H, Furuyama K. Hereditary sideroblastic anemia: pathophysiology and gene mutations. Int J Hematol. 2010;92:425–31.CrossRefPubMed
9.
go back to reference Aivado M, Gattermann N, Rong A, Giagounidis AA, Prall WC, Czibere A, et al. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns. Blood Cells Mol Dis. 2006;37:40–5.CrossRefPubMed Aivado M, Gattermann N, Rong A, Giagounidis AA, Prall WC, Czibere A, et al. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns. Blood Cells Mol Dis. 2006;37:40–5.CrossRefPubMed
10.
go back to reference Gong J, Ferreira GC. Aminolevulinate synthase: functionally important residues at a glycine loop, a putative pyridoxal phosphate cofactor-binding site. Biochemistry. 1995;34:1678–85.CrossRefPubMed Gong J, Ferreira GC. Aminolevulinate synthase: functionally important residues at a glycine loop, a putative pyridoxal phosphate cofactor-binding site. Biochemistry. 1995;34:1678–85.CrossRefPubMed
11.
go back to reference Astner I, Schulze JO, van den Heuvel J, Jahn D, Schubert WD, Heinz DW. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO J. 2005;24:3166–77.CrossRefPubMedPubMedCentral Astner I, Schulze JO, van den Heuvel J, Jahn D, Schubert WD, Heinz DW. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans. EMBO J. 2005;24:3166–77.CrossRefPubMedPubMedCentral
12.
go back to reference Sankaran VG, Ulirsch JC, Tchaikovskii V, Ludwig LS, Wakabayashi A, Kadirvel S, et al. X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation. J Clin Invest. 2015;125:1665–9.CrossRefPubMedPubMedCentral Sankaran VG, Ulirsch JC, Tchaikovskii V, Ludwig LS, Wakabayashi A, Kadirvel S, et al. X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation. J Clin Invest. 2015;125:1665–9.CrossRefPubMedPubMedCentral
Metadata
Title
A Japanese family with X-linked sideroblastic anemia affecting females and manifesting as macrocytic anemia
Authors
Tatsuya Katsurada
Hiroshi Kawabata
Daiki Kawabata
Masahiro Kawahara
Yukiharu Nakabo
Akifumi Takaori-Kondo
Yataro Yoshida
Publication date
01-06-2016
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 6/2016
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-016-1949-7

Other articles of this Issue 6/2016

International Journal of Hematology 6/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine